Gilead, Janssen, Teva Can't Say HIV Drug Costs Passed On

By Bryan Koenig ( April 19, 2023, 9:06 PM EDT) -- Health care insurers going to trial next month in their suit against Gilead, Janssen and Teva won't have to worry about arguments they passed on any overcharges after a California federal judge banned the drugmakers from using that defense in the sprawling certified consumer antitrust class action alleging drugmakers artificially inflated HIV drug prices....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!